Michel Komajda
- Endocrinology, Diabetes and Metabolism top 0.5%
- Surgery top 2%
- Cardiology and Cardiovascular Medicine top 2%
- Molecular Biology top 10%
- Cancer Research top 5%
- Co-authors
- Mark J. CaulfieldCharles L. ShearBryan BrewerMarian R. FisherAlan R. TallJames H. RevkinJosé López‐SendónJohn J.P. Kastelein
- Topics
- Heart Failure Treatment and Management (5 papers)Mitochondrial Function and Pathology (3 papers)Genetic Neurodegenerative Diseases (3 papers)
- Partner nations
- FranceUnited KingdomSpain
In The Last Decade
Michel Komajda
23 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Endocrinology, Diabetes and Metabolism 1.7k
- Surgery 1.7k
- Cardiology and Cardiovascular Medicine 1.0k
- Molecular Biology 830
- Cancer Research 459
Countries citing papers authored by Michel Komajda
This map shows the geographic impact of Michel Komajda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Komajda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Komajda more than expected).
Fields of papers citing papers by Michel Komajda
This network shows the impact of papers produced by Michel Komajda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Komajda. The network helps show where Michel Komajda may publish in the future.
Co-authorship network of co-authors of Michel Komajda
This figure shows the co-authorship network connecting the top 25 collaborators of Michel Komajda. A scholar is included among the top collaborators of Michel Komajda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Komajda. Michel Komajda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 46 | |
| 4 | 71 | |
| 5 | 95 | |
| 6 | 152 | |
| 7 | 32 | |
| 8 | 34 | |
| 9 | Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysisbreakdown → | 561 |
| 10 | Effects of Torcetrapib in Patients at High Risk for Coronary Eventsbreakdown → | 2218 |
| 11 | Randomized controlled trial of the effect of rosiglitazone in combination therapy on ambulatory blood pressure in people with type 2 diabetes mellitus followed for 12 months | 3 |
| 12 | 59 | |
| 13 | 6 | |
| 14 | [Prognostic value of neurohormones in heart failure in clinical practice]. | 1 |
| 15 | 66 | |
| 16 | 1 | |
| 17 | 32 | |
| 18 | [Non invasive evaluation of cardiovascular effects of nebivolol in patients with cardiac insufficiency]. | 4 |
| 19 | 16 | |
| 20 | [Long-term treatment of severe cardiac failure with captopril (author's transl)]. | 1 |
About Michel Komajda
Michel Komajda is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine, having authored 25 papers that have together received 3.5k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (5 papers), Mitochondrial Function and Pathology (3 papers) and Genetic Neurodegenerative Diseases (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Cardiology and Cardiovascular Medicine (1.0k citations) and Surgery (1.7k citations). Michel Komajda has collaborated with scholars based in France, United Kingdom and Spain. Frequent co-authors include Mark J. Caulfield, Charles L. Shear, Bryan Brewer, Marian R. Fisher, Alan R. Tall, James H. Revkin, José López‐Sendón, John J.P. Kastelein, Lori Mosca and Jean‐Claude Tardif. Their work appears in journals such as New England Journal of Medicine, Circulation and Journal of Applied Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.